Cholesterol accumulation promotes ABCA1 degradation in astrocytes via Caveolin‐1 mediated endocytosis in ApoE4.

Background: Apolipoprotein E4 (ApoE4) dysregulates cholesterol metabolism in the brain promoting the accumulation of lipid droplets, synaptic dysfunction and associates with a greater Alzheimer's disease risk. We previously demonstrated that ApoE4 reduces the function of ATP‐binding cassette transporters A1 (ABCA1) which has important roles in cholesterol transport. The mechanisms of how ApoE4 induces less ABCA1 activity are poorly understood. Method: ABCA1 binding proteins were analyzed with mass spectrum after immunoprecipitation. Immortalized astrocytes, primary astrocytes, mouse brain and human postmortem brain samples were used to test the association of ABCA1 and caveolin‐1 levels. Small interfere RNA was used to knockdown caveolin‐1 expression and 3H labelled cholesterol was used to test the cholesterol efflux of ABCA1. Result: Here, we enriched ABCA1 binding protein complexes from ABCA1‐overexpressing cells treated with recombinant ApoE3 or ApoE4 proteins for a proteomic screen implicating endocytosis as a major pathway differentiating ApoE3 from ApoE4. Among the protein targets discovered, caveolin‐1 expression increased after ApoE4 treatment. Caveolin‐1 and ABCA1 interactions were confirmed using immunoprecipitation experiments. Cholesterol accumulation in astrocytes induced caveolin‐1 expression and promoted ABCA1 degradation. Greater caveolin‐1 and lower ABCA1 expression was observed in brains of 8, 18 and 22 months‐old ApoE4‐TR mice compared with the corresponding ApoE3‐TR mice. Isolation of single cell types from adult mouse ApoE‐TR brains confirmed lower ABCA1 and greater caveolin‐1 expression was largely driven by astrocytes and not microglia or neurons enriched fractions. Conclusion: In conclusion, cholesterol accumulation induced by ApoE4 promotes ABCA1 degradation in astrocytes partly through a caveolin‐1 dependent endocytosis pathway. [ABSTRACT FROM AUTHOR]